About
Keith L. Crandell has served on the 908 Devices board since June 2012. He is a co-founder and managing director of ARCH Venture Partners, an early-stage technology venture capital firm, where he has worked since July 1994. He serves on the board of Twist Bioscience and previously served on the board of Quanterix. He holds a B.S. in chemistry and mathematics from St. Lawrence University, an M.S. in chemistry from the University of Texas at Arlington, and an MBA from the University of Chicago.
Roles
908 Devices Inc.
Director · Current role
June 2012–present
ARCH Venture Partners
Co-Founder and Managing Director
July 1994 - present
External Roles
Twist Bioscience
Director
—
Quanterix Corporation
Director
June 2007 - June 2023
Director Compensation
FY 2025Fees earned or paid in cash
$67,500
ComponentBoard and committee cash retainers earned in FY2025
Stock awards
$101,257
ComponentAnnual RSU grant, ASC 718 grant-date fair value
Option awards
$33,753
ComponentAnnual NQSO grant, ASC 718 grant-date fair value
Total
$202,510
Also at 908 Devices Inc.
See how Top Bucket AI works for your firm
Request DemoTop Bucket AI Research
Stay ahead of private markets
Research and market intelligence for private-markets professionals.
✓
You're subscribed.
Thanks for signing up.